Avadel Pharmaceuticals plc (AVDL)
Market Closed
13 Feb, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
21. 64
0
0%
$
2.12B Market Cap
- P/E Ratio
- Div Yield
35.02M Volume
-1.83 Eps
$ 21.64
Previous Close Investors:
Want to track AVDL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avadel Pharmaceuticals plc (AVDL) Statistics
Valuation metrics
Market Cap 2.12B
Enterprise value 2.08B
Trailing P/E (ttm) 431.08
Forward P/E -
PEG ratio 0.66
Price/Sales (ttm) 10.72
Price/Book (mrq) 21.39
Enterprise Value/Revenue 10.51
Enterprise Value/EBITDA 177.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 6.38
52-Week high 23.57
Beta -
50-Day moving average -
200-Day moving average 21.55
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.02%
Operating margin 0.04%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.94
Total debt (mrq) -
Total Debt/Equity (mrq) 0.38
Current ratio (mrq) 2.76%
Book value per share (mrq) 1.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
